Immunogenicity of P/Q-type calcium channel in small cell lung cancer: Investigation of α1 subunit polyglutamine expansion

Tissue Antigens

Volumn 54, Issue 6, 1999, Pages 592-596

  Black III, J L ^a   Nelson, T R ^a   Snow, K ^a   Lennon, Vanda A ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Lambert Eaton myasthenic syndrome; P Q type voltage gated calcium channel; Paraneoplastic autoimmunity

Indexed keywords

CALCIUM CHANNEL; POLYGLUTAMINE; PROTEIN SUBUNIT; TUMOR PROTEIN;

ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; EATON LAMBERT SYNDROME; GENE AMPLIFICATION; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOGENICITY; LUNG SMALL CELL CANCER; MYASTHENIA GRAVIS; NEUROLOGIC DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPINOCEREBELLAR DEGENERATION; TRINUCLEOTIDE REPEAT; TUMOR CELL;

AUTOIMMUNITY; CALCIUM CHANNELS, N-TYPE; CARCINOMA, SMALL CELL; HUMANS; LAMBERT-EATON MYASTHENIC SYNDROME; LUNG NEOPLASMS; MUTATION; REPETITIVE SEQUENCES, NUCLEIC ACID; SEQUENCE ANALYSIS, DNA;

ATAXIA;

EID: 0033398551     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.1999.540609.x     Document Type: Article

References (23)

1. 1. Oguro-Okano M, Griesmann GE, Wieben ED, Slaymaker S, Snutch TP, Lennon VA. Molecular diversity of neuronal type calcium channels identified in small cell lung carcinoma. Mayo Clin Proc 1992: 67: 1150-9.
2. 3 muscarinic acetylcholine receptors inhibits voltage-dependent calcium influx in small cell lung carcinoma. J Biol Chem 1990: 265: 1443-7.
3. 3. Codignola A, Tarroni P, Clementi F et al. Calcium channel subtypes controlling serotonin release from human small cell lung carcinoma cell lines. J Biol Chem 1993: 268: 26240-7.
4. 4. Lennon VA, Kryzer TJ, Griesmann GE et al. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 1995: 332: 1467-74.
5. 5. Miljanich GP, Ramachandran J. Antagonists of neuronal calcium channels: structure, function and therapeutic implications. Annu Rev Pharmacol Toxicol 1995: 35: 707-34.
6. 6. Sugiura Y, Woppmann R, Miljanich GP, Ko C-P. A novel ω-conopeptide for the presynaptic localization of calcium channels at the mammalian neuromuscular junction. J Neurocytol 1995: 24: 15-27.
7. 2+ channel. J Biol Chem 1996: 271: 13804-10.
8. 8. Black JL, Lennon VA. The identification and cloning of human neuronal high voltage-gated calcium channel γ-2 and γ-3 subunits: Neurological implications. Mayo Clin Proc 1999: 74: 357-61.
9. 9. De Waard M, Liu H, Walker D, Scott VE, Gurnett CA, Campbell KP. Direct binding of G-protein betagamma complex to voltage-dependent calcium channels. Nature 1997: 385: 446-50.
10. 10. Bourinet E, Soong TW, Sutton K et al. Splicing of α1A subunit gene generates phenotypic variants of P-and Q-type calcium channels. Nat Neurosci 1999: 2: 407-15.
11. 1A-voltage-dependent calcium channel. Nat Genet 1997: 15: 62-9.
12. 12. Andrew SE, Goldberg YP, Hayden MR. Rethinking genotype and phenotype correlations in polyglutamine expansion disorders. Hum Mol Genet 1997: 12: 2005-10.
13. 13. Lopes-Cendes I, Maciel P, Kish S et al. Somatic mosaicism in the central nervous system in spinocerebellar ataxia type 1 and Machado-Joseph disease. Ann Neurol 1996: 40: 199-206.
14. 14. Koshy BT, Zoghbi HY. The CAG/ polyglutamine tract diseases: gene products and molecular pathogenesis. Brain Pathol 1997: 7: 927-42.
15. 15. Gouw LG, Castaneda MA, McKenna CK et al. Analysis of the dymanic mutation in the SCA7 gene shows marked parental effects on CAG repeat transmission. Hum Mol Genet 1998: 7: 525-32.
16. 2+ channel gene CACNL1A4. Cell 1996: 87: 543-52.
17. 1A subunit of the voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome. Neurology 1997: 48: 1261-5.
18. 18. Lennon VA. Immunological mechanisms in myasthenia gravis - a model of a receptor disease. In: Franklin E, ed. Clinical Immunology Update: Reviews for Physicians. New York: Elsevier North Holland, 1979: 259-89.
19. 19. De Aizpurua HJ, Lambert EH, Griesmann GE, Olivera BM, Lennon VA. Antagonism of voltage-gated calcium channels in small cell carcinomas of patients with and without Lambert-Eaton myasthenic syndrome by autoantibodies, ω-conotoxin and adenosine. Cancer Res 1988: 48: 4719-24.
20. 7) types coexpressed in a small cell lung carcinoma. J Neurochem 1997: 69: 2302-11.
21. 1-subunit expressed in a small cell lung carcinoma cell line. Mol Biol Cell 1996: 7 (Suppl): 254a.
22. 2+ channels. J Neurosci 1998: 18: 641-7.
23. 2+ channel α2δ subunit in current stimulation and subunit interaction. Neuron 1996: 16: 431-40.